Cargando…
Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells
Autores principales: | Manley, Sharon J., Olou, Appolinaire A., Jack, Jarrid L., Ruckert, Mariana T., Walsh, R. McKinnon, Eades, Austin E., Bye, Bailey A., Ambrose, Joe, Messaggio, Fanuel, Anant, Shrikant, VanSaun, Michael N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861165/ https://www.ncbi.nlm.nih.gov/pubmed/35190546 http://dx.doi.org/10.1038/s41419-022-04615-0 |
Ejemplares similares
-
Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells
por: Manley, Sharon J., et al.
Publicado: (2022) -
SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1
por: Olou, Appolinaire A., et al.
Publicado: (2022) -
AdipoRon may be benefit for atherosclerosis prevention
por: Esfahani, Maryam, et al.
Publicado: (2017) -
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
por: Nigro, Ersilia, et al.
Publicado: (2021) -
AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
por: Abou‐Samra, Michel, et al.
Publicado: (2020)